Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU – Get Free Report)’s stock price dropped 0.1% on Wednesday . The stock traded as low as $10.14 and last traded at $10.14. Approximately 1,957 shares were traded during trading, a decline of 98% from the average daily volume of 79,217 shares. The stock had previously closed at $10.15.
Drugs Made in America Acquisition Trading Up 0.2 %
The company has a fifty day moving average of $10.12.
Drugs Made in America Acquisition Company Profile
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
Read More
- Five stocks we like better than Drugs Made in America Acquisition
- Overbought Stocks Explained: Should You Trade Them?
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Using the MarketBeat Dividend Yield Calculator
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- 5 Top Rated Dividend Stocks to Consider
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Drugs Made in America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
